CQ Roll Call on #Path2Cures: “A novel initiative that brings issue advocates directly into the deliberations process.”
21st Century Cures continues this week with a roundtable on Tuesday, June 24 at 10 a.m. to discuss how advances in technology can be used to accelerate the discovery, development, and delivery cycle of new cures and treatments. “This initiative is truly unique. We’re taking the time to listen and engage with people all across the country to learn what they think can be done to improve the cycle of cures,” commented Energy and Commerce Committee Chairman Fred Upton (R-MI). “We know that this must be a collaborative effort and through our email@example.com email, Facebook page, Twitter account, and dedicated hashtag, #Path2Cures, we hope to reach everyone. All Americans are affected by disease – whether they themselves or a loved one. These perspectives and personal experiences are driving this conversation and we have been encouraged by the outpouring of ideas.”
June 20, 2014
House Energy & Commerce on the #Path2Cures
Developing policy for complex and technologically-sophisticated industries like health care is difficult work for legislative bodies. To deal with the multifaceted issue of how to bring new treatments for disease to the market more quickly, the House Energy and Commerce Committee recently launched a novel initiative that brings issue advocates directly into the deliberations process.
Named Energy and Commerce Cures, the initiative will focus on how to best reform the overlapping federal regulations and laws that govern the drug approval process to make it faster and more innovative. Like most congressional panels, the committee has invited a variety of representatives from federal agencies, the private sector, academia, and advocacy groups to participate in roundtable discussions of white papers. What makes this effort unique is that even those advocates not invited to sit at the conference table are encouraged to join in the discussion through social media. …
Read the article online HERE.